Suppr超能文献

针对1型单纯疱疹病毒的多表位疫苗的计算设计与评估

Computational design and evaluation of multiepitope vaccines against herpes simplex virus type 1.

作者信息

Zhao Zibo, Wang Weixiong, Pang Jiaping, Zhou Bei, Li Xin, Wang Yifei, Zheng Kai, Ren Zhe

机构信息

Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China.

Guangdong Province Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou, China.

出版信息

Front Immunol. 2025 Jun 4;16:1581571. doi: 10.3389/fimmu.2025.1581571. eCollection 2025.

Abstract

INTRODUCTION

Herpes simplex virus type 1 (HSV-1) is a prevalent human pathogen, causing infections in various tissues and leading to severe complications such as herpes simplex encephalitis and cognitive impairments. Despite existing antiviral treatments, recurrent infections and the lack of effective vaccines highlight the need for new preventive measures.

METHODS

We employed immunogenomic and bioinformatics methods to design two multi-epitope vaccine constructs 1 and 2 against HSV-1. The Immune Epitope Database was used to identify B-cell and T-cell epitopes from HSV-1 glycoproteins. The IFN epitope server and the IL4pred/IL-10pred server were used to ascertain the activation possibility of IFN-γ, IL-4, and IL-10. The NetMHC-4.0 and NetMHCII2.3 servers were used to identify MHC epitopes. The constructed vaccine was analyzed for antigenicity and allergenicity using the VaxiJen v2.0 and AllergenFP servers. The three-dimensional structure of the vaccine construct was constructed using the AlphaFold3 tool. The ClusPro 2.0 server was utilized for molecular docking and the Desmond module in Schrodinger 2021-1 was utilized for molecular dynamics and MM/PBSA analysis. The immunogenicity and the corresponding immune response curves were analyzed using the C-ImmSim server.

RESULTS

Bioinformatics analysis demonstrated that these vaccines exhibited both good affinity and immunogenicity, and were non-toxic and non-allergenic to the host. In addition, vaccine construct 2 exhibits superior stability and binding affinity with TLR9, and is more effective in triggering a robust immune response.

DISCUSSION

This approach targets the key mechanisms of HSV-1 entry and TLR-mediated immune responses, providing a potential strategy for preventing and treating HSV-1 infections. Furthermore, the identified and optimized vaccine construct offers a promising avenue for developing a preventive vaccine against HSV-1, addressing the critical need for better control of this widespread virus.

摘要

引言

单纯疱疹病毒1型(HSV-1)是一种常见的人类病原体,可在各种组织中引发感染,并导致严重并发症,如单纯疱疹病毒性脑炎和认知障碍。尽管现有抗病毒治疗方法,但复发性感染以及缺乏有效的疫苗凸显了采取新预防措施的必要性。

方法

我们采用免疫基因组学和生物信息学方法设计了两种针对HSV-1的多表位疫苗构建体1和2。利用免疫表位数据库从HSV-1糖蛋白中鉴定B细胞和T细胞表位。使用IFN表位服务器以及IL4pred/IL-10pred服务器来确定IFN-γ、IL-4和IL-10的激活可能性。使用NetMHC-4.0和NetMHCII2.3服务器鉴定MHC表位。使用VaxiJen v2.0和AllergenFP服务器分析构建的疫苗的抗原性和致敏性。使用AlphaFold3工具构建疫苗构建体的三维结构。利用ClusPro 2.0服务器进行分子对接,并利用Schrodinger 2021-1中的Desmond模块进行分子动力学和MM/PBSA分析。使用C-ImmSim服务器分析免疫原性和相应的免疫反应曲线。

结果

生物信息学分析表明,这些疫苗具有良好的亲和力和免疫原性,对宿主无毒且无致敏性。此外,疫苗构建体2表现出更高的稳定性以及与TLR9的结合亲和力,并且在触发强烈免疫反应方面更有效。

讨论

这种方法针对HSV-1进入和TLR介导的免疫反应的关键机制,为预防和治疗HSV-感染提供了一种潜在策略。此外,所鉴定和优化的疫苗构建体为开发针对HSV-1的预防性疫苗提供了一条有前景的途径,满足了更好地控制这种广泛传播病毒(的迫切需求)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d9/12174051/7ad89b76b17b/fimmu-16-1581571-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验